Novo Nordisk, in a mixed-bag earnings report, beat expectations on Wegovy sales but tightened its 2024 outlook
Novo Nordisk reported mixed Q3 earnings, but GLP-1 drugs contributed to revenue strength. The company also adjusted its year-end outlook. Wall Street wasn't cheery about that.
BeiGene: TEVIMBRA European Push Continues With Positive CHMP Opinion
BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...
Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died
Novo Nordisk said on Wednesday it was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs. U.S. regulations allow ...
tyla7h
Adam Lambert reveals drastic weight loss as he shares what happened when he switched from Ozempic to different drug
Queen and American Idol star Adam Lambert revealed he has lost 60lbs and says it happened after switching from Ozempic.
Novo Nordisk is aware of 10 deaths from compounded weight-loss drug copies
Novo Nordisk said on Wednesday it is aware of 10 deaths and 100 hospitalizations resulting from people taking compounded copies of its weight-loss and diabetes drugs, and the CEO said he is alarmed by ...
NDTV16h
What Is Ozempic? Is It Safe For Weight Loss? Here's Why You Should Be Informed Before Using It
While Ozempic has been shown to lead to weight loss as a side effect, it's not without risks. According to the Cleveland ...